INTRODUCTION
Rosacea is an inflammatory skin disorder with at least a 10% prevalence reported among White adults and limited data in people with skin of color.1 However, the condition is not rare in people of Latin-American descent.1,2 The clinical presentation of rosacea in richly pigmented phototypes may be less visible and therefore overlooked. International guidelines for rosacea diagnosis and treatment will be reviewed, with emphasis on promoting a healthy skin barrier using skincare products as adjunctive therapy.
Rosacea Diagnosis
The first challenge in meeting the needs of patients with rosacea is a correct diagnosis. There is no consensus outlining rosacea diagnosis and treatment specific to people of Latin America. An international panel of dermatologists and ophthalmologists, the global ROSacea COnsensus panel (ROSCO), is recognized for its ongoing updates for the management of rosacea based on a phenotype rather than a subtype approach.3,4 A phenotype approach allows for rosacea treatment based on a patient's presenting disease features, thus fostering individualized care. The wisdom of a phenotypic approach to diagnosis and treatment is reflected in evidence-based systematic reviews of best practices for managing rosacea, which have incorporated a phenotypic approach to reviews of rosacea-specific research.5
Phenotype-Based Rosacea Classification
The findings of rosacea are not unique, which leads to underdiagnosis.6 The erythema and papulopustular lesions seen in rosacea can be mistaken for seborrheic dermatitis, acne vulgaris, flushing disorders, lupus erythematosus, dermatomyositis, contact dermatitis, or photodamaged skin.6
Rosacea Diagnosis
The first challenge in meeting the needs of patients with rosacea is a correct diagnosis. There is no consensus outlining rosacea diagnosis and treatment specific to people of Latin America. An international panel of dermatologists and ophthalmologists, the global ROSacea COnsensus panel (ROSCO), is recognized for its ongoing updates for the management of rosacea based on a phenotype rather than a subtype approach.3,4 A phenotype approach allows for rosacea treatment based on a patient's presenting disease features, thus fostering individualized care. The wisdom of a phenotypic approach to diagnosis and treatment is reflected in evidence-based systematic reviews of best practices for managing rosacea, which have incorporated a phenotypic approach to reviews of rosacea-specific research.5
Phenotype-Based Rosacea Classification
The findings of rosacea are not unique, which leads to underdiagnosis.6 The erythema and papulopustular lesions seen in rosacea can be mistaken for seborrheic dermatitis, acne vulgaris, flushing disorders, lupus erythematosus, dermatomyositis, contact dermatitis, or photodamaged skin.6
